US Stock MarketDetailed Quotes

Psyence Biomedical (PBM)

Watchlist
  • 5.870
  • +2.990+103.82%
Close Apr 16 16:00 ET
  • 7.420
  • +1.550+26.41%
Post 20:01 ET
6.73MMarket Cap-0.45P/E (TTM)

Psyence Biomedical (PBM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2025
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.78%-3.73M
-85.00%-2.95M
-14.01%-1.59M
-1.4M
Net income from continuing operations
101.98%1.01M
-1,495.53%-51.16M
-72.55%-3.21M
---1.86M
Operating gains losses
-1,927.92%-519.31K
133.62%28.41K
---84.5K
----
Depreciation and amortization
1,678.33%4.27K
--240
--0
----
Other non cash items
-99.50%218.41K
--43.58M
----
----
Change In working capital
67.07%-386.2K
-179.39%-1.17M
1,038.80%1.48M
--129.74K
-Change in receivables
-188.83%-95.6K
197.96%107.62K
-209.80%-109.86K
--100.05K
-Change in prepaid assets
128.70%70.33K
-241.97%-245.08K
-56,019.30%-71.67K
--128.1579
-Change in payables and accrued expense
65.14%-360.93K
-162.41%-1.04M
5,511.67%1.66M
--29.56K
Cash from discontinued investing activities
Operating cash flow
-26.78%-3.73M
-85.00%-2.95M
-14.01%-1.59M
---1.4M
Investing cash flow
Cash flow from continuing investing activities
-183.39%-16.23K
-5.73K
0
-32.04K
Net PPE purchase and sale
-72.46%-9.88K
---5.73K
--0
----
Net other investing changes
---6.35K
----
----
---32.04K
Cash from discontinued investing activities
Investing cash flow
-183.39%-16.23K
---5.73K
--0
---32.04K
Financing cash flow
Cash flow from continuing financing activities
289.47%9.15M
100.35%2.35M
172.07%1.17M
-1.63M
Net issuance payments of debt
215.34%7.41M
--2.35M
--0
----
Net common stock issuance
--1.74M
--0
--0
----
Net other financing activities
----
----
172.07%1.17M
---1.63M
Cash from discontinued financing activities
Financing cash flow
289.47%9.15M
100.35%2.35M
172.07%1.17M
---1.63M
Net cash flow
Beginning cash position
-45.05%733.19K
-23.90%1.33M
-63.55%1.75M
--4.81M
Current changes in cash
998.69%5.4M
-43.40%-601.09K
86.28%-419.16K
---3.06M
End cash Position
736.78%6.14M
-45.05%733.19K
-23.97%1.33M
--1.76M
Free cash flow
-26.87%-3.74M
-85.36%-2.95M
-14.01%-1.59M
---1.4M
Currency Unit
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
--
--
(FY)Mar 31, 2025(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.78%-3.73M-85.00%-2.95M-14.01%-1.59M-1.4M
Net income from continuing operations 101.98%1.01M-1,495.53%-51.16M-72.55%-3.21M---1.86M
Operating gains losses -1,927.92%-519.31K133.62%28.41K---84.5K----
Depreciation and amortization 1,678.33%4.27K--240--0----
Other non cash items -99.50%218.41K--43.58M--------
Change In working capital 67.07%-386.2K-179.39%-1.17M1,038.80%1.48M--129.74K
-Change in receivables -188.83%-95.6K197.96%107.62K-209.80%-109.86K--100.05K
-Change in prepaid assets 128.70%70.33K-241.97%-245.08K-56,019.30%-71.67K--128.1579
-Change in payables and accrued expense 65.14%-360.93K-162.41%-1.04M5,511.67%1.66M--29.56K
Cash from discontinued investing activities
Operating cash flow -26.78%-3.73M-85.00%-2.95M-14.01%-1.59M---1.4M
Investing cash flow
Cash flow from continuing investing activities -183.39%-16.23K-5.73K0-32.04K
Net PPE purchase and sale -72.46%-9.88K---5.73K--0----
Net other investing changes ---6.35K-----------32.04K
Cash from discontinued investing activities
Investing cash flow -183.39%-16.23K---5.73K--0---32.04K
Financing cash flow
Cash flow from continuing financing activities 289.47%9.15M100.35%2.35M172.07%1.17M-1.63M
Net issuance payments of debt 215.34%7.41M--2.35M--0----
Net common stock issuance --1.74M--0--0----
Net other financing activities --------172.07%1.17M---1.63M
Cash from discontinued financing activities
Financing cash flow 289.47%9.15M100.35%2.35M172.07%1.17M---1.63M
Net cash flow
Beginning cash position -45.05%733.19K-23.90%1.33M-63.55%1.75M--4.81M
Current changes in cash 998.69%5.4M-43.40%-601.09K86.28%-419.16K---3.06M
End cash Position 736.78%6.14M-45.05%733.19K-23.97%1.33M--1.76M
Free cash flow -26.87%-3.74M-85.36%-2.95M-14.01%-1.59M---1.4M
Currency Unit USDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More